Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(TSV: ZYUS )

1.020 UNCHANGED
Streaming Delayed Price Updated: 1:23 PM EDT, Jun 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,000
Open 1.020
Bid (Size) 1.010 (21)
Ask (Size) 1.050 (25)
Prev. Close 1.020
Today's Range 1.020 - 1.020
52wk Range 0.7100 - 1.190
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9
From ZYUS Life Sciences Corporation
Via Business Wire
ZYUS Life Sciences Receives United States Patent No. 11,963,943 Covering Pain Management
From ZYUS Life Sciences Corporation
Via Business Wire

Performance

YTD
+14.61%
+14.61%
1 Month
-7.27%
-7.27%
3 Month
-7.27%
-7.27%
6 Month
+14.61%
+14.61%
1 Year
-1.92%
-1.92%

More News

Read More
Top Cannabis Appointments You Should Know About: Aurora's New CFO And Other Changes
Via Benzinga
Topics Cannabis
Exposures Cannabis
ZYUS Strengthens Expertise of Clinical Advisory Committee with the Appointment of Dr. Hance Clarke
From ZYUS Life Sciences Corporation
Via Business Wire
ZYUS Strengthens Leadership Team with Appointment of Vice President of Clinical Research
From ZYUS Life Sciences Corporation
Via Business Wire
ZYUS Life Sciences Corporation Announces Phase 2 Clinical Trial Evaluating Trichomylin® Softgel Capsules for Advanced Cancer Pain Management
From ZYUS Life Sciences Corporation
Via Business Wire
ZYUS Life Sciences Corporation Announces Positive Phase I Clinical Trial Results for Trichomylin® Softgels
From ZYUS Life Sciences Corporation
Via Business Wire
ZYUS Life Sciences Corporation Announces New Director of Investor Relations and Capital Markets
From ZYUS Life Sciences Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.